Utmost

AstraZeneca, a global, science-led, patient-focused biopharmaceutical company, has selected Utmost and its modern Extended Workforce System (EWS) to manage their external workforce, including 34,000 contingent and outsourced service…
Read More...

Utmost raises Series B to continue evolving vendor management systems and address the full continuum of workers Utmost, the first extended workforce system, announced it has raised $21 million in Series B funding. Through its native…
Read More...